We are thrilled to lead the $2.5 million financing round in QSimulate, which uses quantum simulations for drug discovery. Congratulations to Toru Shiozaki, Garnet Chan and the whole team! As Niels Nielsen, co-founder of 2xN, said: "QSimulate stands at the forefront of revolutionizing drug design and material science, and we're convinced they're only scratching the surface with their already state-of-the-art QM-based simulation methods. With quantum computing on the rise, the interplay between classical and quantum computing will define the future of computation. QSimulate is well-positioned to benefit from this, having on board both quantum and classical simulation experts. The ongoing collaborations with JSR Corporation and Google Quantum AI are a testament to QSimulate’s pioneering position in harnessing quantum mechanics for drug discovery and materials innovation, setting a new industry benchmark." #quantumtechnology #startup #quantum #drugdiscovery #materialsscience #innovation #vc #funding https://lnkd.in/e2QGYhUy
2xN
Venture Capital and Private Equity Principals
Quantum-inspired VC fund bringing the true value of network effects to early-stage founders.
About us
2xN is a quantum-inspired early-stage VC fund. 2xN was founded by Lars Fjeldsoe-Nielsen, a Silicon Valley operator turned investor, and Niels Nielsen, an entrepreneur and pioneer investor in Quantum Computing to bring the true, high-growth value of network effects to early-stage founders. The 2xN team offers a unique “best of both worlds” approach that merges the platform service typically seen from institutional investors with the kind of dedicated, hands-on trusted support of angels.
- Website
-
https://www.2xn.vc/
External link for 2xN
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- United Kingdom
- Type
- Privately Held
- Founded
- 2021
- Specialties
- Quantum Computing, Venture capital, and entrepreneurship
Locations
-
Primary
Get directions
London
United Kingdom, GB